EMA Backs Approval of Elahere for Ovarian Cancer ...Middle East

Medscape - News
Elahere was found to improve survival in patients with FR-alpha–positive, platinum-resistant, high-grade serous epithelial ovarian, fallopian tube, or primary peritoneal cancer. Medscape Medical News

Hence then, the article about ema backs approval of elahere for ovarian cancer was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( EMA Backs Approval of Elahere for Ovarian Cancer )

Apple Storegoogle play

Last updated :

Also on site :



Latest News